Literature DB >> 1426335

The value of repeat hysteroscopic evaluation in patients with failed in vitro fertilization transfer cycles.

D Dicker1, J Ashkenazi, D Feldberg, J Farhi, J Shalev, Z Ben-Rafael.   

Abstract

One hundred ten women with normal initial hysteroscopy who failed to conceive during three or more IVF-ET cycles underwent repeat hysteroscopic evaluation. In 20 patients (18.2%), visualization revealed uterine abnormalities, mainly newly added endometrial lesions, i.e., hyperplasia, polyps, endometritis, and synechiae. Our results indicate that repeat hysteroscopic evaluation, in cases of recurrent IVF-ET failure, is an important adjunctive method for further evaluating and possibly optimizing the IVF-ET procedure.

Entities:  

Mesh:

Year:  1992        PMID: 1426335     DOI: 10.1016/s0015-0282(16)55338-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  Impact of office hysteroscopy in repeated implantation failure: Experience of a single center.

Authors:  Emre Göksan Pabuçcu; İbrahim Yalçın; Taylan Bodur; Gamze Sinem Çağlar; Recai Pabuçcu
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-12-01

2.  The effect of endometrial polyps on outcomes of in vitro fertilization (IVF) cycles.

Authors:  A Lass; G Williams; N Abusheikha; P Brinsden
Journal:  J Assist Reprod Genet       Date:  1999-09       Impact factor: 3.412

3.  Comparison between findings of saline infusion sonohysterography and office hysteroscopy in patients with recurrent implantation failure.

Authors:  Ahmed Reda; Ahmed Sherif Abdel Hamid; Rowaa Mostafa; Eman Refaei
Journal:  J Hum Reprod Sci       Date:  2016 Oct-Dec

4.  A multi-centre randomised controlled study of pre-IVF outpatient hysteroscopy in women with recurrent IVF implantation failure: Trial of Outpatient Hysteroscopy - [TROPHY] in IVF.

Authors:  Tarek El-Toukhy; Rudi Campo; Sesh Kamal Sunkara; Yacoub Khalaf; Arri Coomarasamy
Journal:  Reprod Health       Date:  2009-12-03       Impact factor: 3.223

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.